Focal hand dystonia in a patient with PANK2 mutation

Movement Disorders

Volumn 23, Issue 3, 2008, Pages 466-468

  Chung, Sun J ^a   Lee, Jae Hong ^a   Lee, Myoung C ^a   Yoo, Han Wook ^a   Kim, Gu Hwan ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CARBIDOPA PLUS LEVODOPA; PANTOTHENATE KINASE 2; TRIHEXYPHENIDYL; PANTOTHENATE KINASE; PHOSPHOTRANSFERASE;

ADULT; ARTICLE; BRAIN DYSFUNCTION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DYSGRAPHIA; DYSTONIA; FOCAL HAND DYSTONIA; FRONTAL LOBE; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; HAND; HOMOZYGOSITY; HUMAN; INVOLUNTARY MOVEMENT; MALE; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT RESPONSE; BRAIN; GENETICS; LETTER; METHODOLOGY; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; BRAIN; DYSTONIC DISORDERS; HAND; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

EID: 43049158213     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21880     Document Type: Article

References (11)

1. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345-349.
2. Thomas M, Hayflick SJ, Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantotherate kinase-associated neurodegeneration. Mov Disord 2004;19:36-42.
3. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 2001;11:863-874.
4. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002;30:3994-3900.
5. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348:33-40.
6. Hayflick SJ, Hartman M, Coryell J, Gitschier J, Rowley H. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am J Neuroradiol 2006;27:1230-1233.
7. Zolkipli Z, Dahmoush H, Saunders DE, Chong WK, Surtees R. Pantothenate kinase 2 mutation with classic pantothenate-kinase-associated neurodegeneration without 'eye-of-the-tiger' sign on MRI in a pair of siblings. Pediatr Radiol 2006;36:884-886.
8. Valentino P, Annesi G, Ciro Candiano IC, et al. Genetic heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern. Mov Disord 2006;21:252-254.
9. Kumar N, Boes CJ, Babovic-Vuksanovic D, Boeve BF. The "eye-of-the-tiger" sign is not pathognomonic of the PANK2 mutation. Arch Neurol 2006;63:292-293.
10. Thomas M, Jankovic J. Neurodegenerative disease and iron storage in the brain. Curr Opin Neurol 2004;17:437-442.
11. Hartig MB, Hortnagel K, Garavaglia B, et al. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol 2006;59: 248-256.